1-7 of 7
R. Angelo de Claro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm

Clinical Trials & Observations
Anthony M. Hunter, Mrinal M. Patnaik, Raphael Itzykson, Ruben Mesa, Chatchada Karanes, Yanxia Li, R. Angelo de Claro, Kelly J. Norsworthy, Marc Theoret, Elizabeth Pulte, Eric Padron
Journal: Blood
Blood (2024) 144 (19): 1987–1992.
https://doi.org/10.1182/blood.2024025648
Published: 2024
Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Nina Kim, Xin Wang, Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne D. Pulte, Marc R. Theoret, R. Angelo De Claro, Kelly J. Norsworthy
Journal: Blood
Blood (2024) 144 (Supplement 1): 1829.
https://doi.org/10.1182/blood-2024-208514
Published: 2024
Journal Articles

FDA Analysis of Race and Ethnic Enrollment of Clinical Trials for Drug Registration in Adult Patients for Leukemia and Myelodysplastic Syndrome

Ashley C. Woods, Dianne D. Pulte, Kamar Godder, Emily Jen, Nina Kim, Robert Le, Catherine C. Lerro, Donna Rivera, Gulsum Pamuk, Nicole J. Gormley, Marc R. Theoret, Kelly J. Norsworthy, R. Angelo De Claro
Journal: Blood
Blood (2024) 144 (Supplement 1): 3806.
https://doi.org/10.1182/blood-2024-204164
Published: 2024
Journal Articles

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Clinical Trials & Observations
Robert Q. Le, Donna Przepiorka, Haiyan Chen, Yuan Li Shen, E. Dianne Pulte, Kelly Norsworthy, Marc R. Theoret, R. Angelo De Claro
Journal: Blood
Blood (2024) 144 (2): 206–215.
https://doi.org/10.1182/blood.2023023313
Published: 2024
Includes: Supplemental data
Journal Articles

Response Prediction to Isocitrate Dehydrogenase (IDH) Inhibitors in Patients with IDH1 - or IDH2 -Mutated Acute Myeloid Leukemia Using Clinical and Genomic Data

Emma C. Scott, Kamil Kural, Sean Smith, Michael Colgan, Alexander J. Ambinder, Gabriel Ghiaur, Nora Holmes, Dickran Kazandjian, Catherine Lai, Colleen McGuire, Lorraine Pelosof, Svetlana Petrovskaya, V. Ashutosh Rao, Amy Rosenberg, Luis Santana-Quintero, Joseph Wynne, Wenming Xiao, Yong Zhang, R. Angelo de Claro, Richard Pazdur, Julia A. Beaver, Kelly J. Norsworthy
Journal: Blood
Blood (2021) 138 (Supplement 1): 1285.
https://doi.org/10.1182/blood-2021-147099
Published: 2021
Journal Articles

FDA Oncology Center of Excellence Review of Real World Data Submissions Supporting Drug Development in Hematologic Malignancies

Donna R. Rivera, Jennifer J Lee, Melanie Royce, R. Angelo de Claro, Nicole J. Gormley, Paul G Kluetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 5037.
https://doi.org/10.1182/blood-2021-153503
Published: 2021
Journal Articles

Response Rate, Event-Free Survival (EFS) and Overall Survival (OS) in Higher-Risk Myelodysplastic Syndromes (HR-MDS): U.S. Food and Drug Administration (FDA) Patient-Level Analyses

Nina Kim, Jonathon Vallejo, Jonathan Herz, Thomas Gwise, R. Angelo de Claro, Marc Theoret, Richard Pazdur, Kelly J. Norsworthy
Journal: Blood
Blood (2021) 138 (Supplement 1): 2604.
https://doi.org/10.1182/blood-2021-147558
Published: 2021